Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP563243.RALa8XdNpNzY-Dd1E9uqT6wdac421u-QWX7HP3kQ7TmnQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP563243.RALa8XdNpNzY-Dd1E9uqT6wdac421u-QWX7HP3kQ7TmnQ130_assertion type Assertion NP563243.RALa8XdNpNzY-Dd1E9uqT6wdac421u-QWX7HP3kQ7TmnQ130_head.
- NP563243.RALa8XdNpNzY-Dd1E9uqT6wdac421u-QWX7HP3kQ7TmnQ130_assertion wasGeneratedBy ECO_0000203 NP563243.RALa8XdNpNzY-Dd1E9uqT6wdac421u-QWX7HP3kQ7TmnQ130_provenance.
- NP563243.RALa8XdNpNzY-Dd1E9uqT6wdac421u-QWX7HP3kQ7TmnQ130_assertion wasDerivedFrom befree-20140225 NP563243.RALa8XdNpNzY-Dd1E9uqT6wdac421u-QWX7HP3kQ7TmnQ130_provenance.
- NP563243.RALa8XdNpNzY-Dd1E9uqT6wdac421u-QWX7HP3kQ7TmnQ130_assertion SIO_000772 12220142 NP563243.RALa8XdNpNzY-Dd1E9uqT6wdac421u-QWX7HP3kQ7TmnQ130_provenance.
- NP563243.RALa8XdNpNzY-Dd1E9uqT6wdac421u-QWX7HP3kQ7TmnQ130_assertion evidence source_evidence_literature NP563243.RALa8XdNpNzY-Dd1E9uqT6wdac421u-QWX7HP3kQ7TmnQ130_provenance.
- NP563243.RALa8XdNpNzY-Dd1E9uqT6wdac421u-QWX7HP3kQ7TmnQ130_assertion description "[The focus of this manuscript is to provide an update of the programmes in the US and Canada, provide data in support of p24 antigen replacement by HIV-1 NAT, and discuss the projections of residual risk of HIV, HCV and HBV following NAT and the associated cost/benefit.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP563243.RALa8XdNpNzY-Dd1E9uqT6wdac421u-QWX7HP3kQ7TmnQ130_provenance.